Complementary and alternative medicine in the treatment of acute bronchitis in children: A systematic review

P M Wopker1, M Schwermer1, S Sommer1

  • 1Department of Pediatrics, Gemeinschaftskrankenhaus Herdecke, Germany; Professorship for integrative Pediatrics, Witten/Herdecke University, Faculty of Health, Germany.

Insights

Complementary and alternative medicine (CAM) shows promise for treating acute bronchitis in children, potentially reducing antibiotic use. Further randomized controlled trials are needed to confirm effectiveness.

Area of Science:

  • Pediatrics
  • Integrative Medicine
  • Evidence-Based Medicine

Background:

  • Acute bronchitis is a common pediatric illness with high healthcare utilization.
  • Viral infections cause most acute bronchitis cases, yet antibiotic overuse is prevalent.
  • Complementary and alternative medicine (CAM) may offer alternatives to antibiotics and complement conventional treatments for pediatric acute bronchitis.

Purpose of the Study:

  • To systematically review published literature on complementary and alternative medicine (CAM) for treating acute bronchitis in children.

Main Methods:

  • A systematic literature search was performed using general and CAM-specific databases.
  • A comprehensive search strategy incorporated 65 CAM-associated definitions.

Main Results:

  • The search identified 309 articles, with 18 meeting the inclusion criteria.
  • Investigated CAM categories included herbal medicine (notably Pelargonium sidoides extract EPs® 7630), anthroposophic medicine, and homeopathy.
  • Pelargonium sidoides extract showed efficacy in three placebo-controlled trials and two observational studies. Anthroposophic and homeopathic remedies were also studied.

Conclusions:

  • The reviewed CAM approaches suggest a favorable effect in treating pediatric acute bronchitis.
  • However, only three of the 18 studies were randomized controlled trials (RCTs).
  • Further high-quality RCTs are essential to establish reliable evidence of CAM effectiveness for acute bronchitis in children.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
656
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
934
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K